rs138258236
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_033087.4(ALG2):c.1174G>A(p.Ala392Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000291 in 1,614,246 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_033087.4 missense
Scores
Clinical Significance
Conservation
Publications
- congenital myasthenic syndrome 14Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- ALG2-congenital disorder of glycosylationInheritance: Unknown, AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, PanelApp Australia, Orphanet, Ambry Genetics
- congenital myasthenic syndromes with glycosylation defectInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ALG2 | NM_033087.4 | c.1174G>A | p.Ala392Thr | missense_variant | Exon 2 of 2 | ENST00000476832.2 | NP_149078.1 | |
| ALG2 | XM_047423996.1 | c.895G>A | p.Ala299Thr | missense_variant | Exon 2 of 2 | XP_047279952.1 | ||
| ALG2 | NR_024532.2 | n.1381G>A | non_coding_transcript_exon_variant | Exon 3 of 3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ALG2 | ENST00000476832.2 | c.1174G>A | p.Ala392Thr | missense_variant | Exon 2 of 2 | 1 | NM_033087.4 | ENSP00000417764.1 | ||
| ALG2 | ENST00000319033.7 | c.895G>A | p.Ala299Thr | missense_variant | Exon 2 of 2 | 1 | ENSP00000326609.6 | |||
| ALG2 | ENST00000238477.5 | n.*916G>A | non_coding_transcript_exon_variant | Exon 3 of 3 | 2 | ENSP00000432675.2 | ||||
| ALG2 | ENST00000238477.5 | n.*916G>A | 3_prime_UTR_variant | Exon 3 of 3 | 2 | ENSP00000432675.2 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152238Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000517 AC: 13AN: 251478 AF XY: 0.0000589 show subpopulations
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1461890Hom.: 1 Cov.: 31 AF XY: 0.0000344 AC XY: 25AN XY: 727248 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152356Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74506 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
ALG2-congenital disorder of glycosylation;C4015597:Congenital myasthenic syndrome 14 Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 392 of the ALG2 protein (p.Ala392Thr). This variant is present in population databases (rs138258236, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with ALG2-related conditions. ClinVar contains an entry for this variant (Variation ID: 364203). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at